Organization: Health Canada
Year: 2023
Month: November
Request Number: A-2023-000826
Request Summary: Health Canada currently has two generic submissions under review for the drug Eplerenone. The following information for these submissions: Date of application Manufacturer or Company Class, Product type Submission type Canadian reference product Dosage form Route(s) of administration Medical ingredient(s) Strength.
Disposition: Disclosed in part
Number of pages: 68